Avax Technologies
Avax Technologies is a biotechnology company that specializes in the research and development of cancer vaccines. The company was founded in 1990 and is headquartered in Philadelphia, Pennsylvania. Avax Technologies is known for its innovative approach to cancer treatment, using autologous (self) cells to stimulate the body's immune system to fight cancer.
History[edit]
Avax Technologies was founded in 1990 with the aim of developing novel cancer treatments. The company's initial focus was on melanoma, a type of skin cancer, but it has since expanded its research to include other types of cancer.
Products and Services[edit]
Avax Technologies' main product is the M-Vax vaccine, which is used to treat patients with stage III and IV melanoma. The vaccine is made from the patient's own cancer cells, which are modified in the lab and then reintroduced into the patient's body to stimulate an immune response.
In addition to M-Vax, Avax Technologies also offers a range of other products and services, including AC Vaccine for the treatment of various types of solid tumors, and OVax, a vaccine for the treatment of ovarian cancer.
Research and Development[edit]
Avax Technologies is committed to ongoing research and development in the field of cancer vaccines. The company's research team is constantly working on new and innovative ways to stimulate the body's immune system to fight cancer.
See Also[edit]
 |
This biotechnology company-related article is a stub. |
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
